A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2008-10-16
Summary
The primary goal of this study is to identify a gene or panel of genes which are differentially expressed in lung cells and tissue from asthmatic patients following administration of Ipratropium bromide and eiTher nebulised Albuterol or saline. Each subject in this study will undergo two bronchoscopies.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Asthma Origins and Remission Study
NCT03141814 ·Status: UNKNOWN
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma
NCT02301975 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
NCT01641692 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 ·Status: TERMINATED ·Phase: PHASE1
-
Phenotyping Disease Severity in Asthma
NCT05078021 ·Status: RECRUITING
-
Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
NCT00127166 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
NCT04503460 ·Status: UNKNOWN ·Phase: PHASE4
-
Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma
NCT04167280 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
The Effect of Benralizumab on Exercise-induced Bronchoconstriction
NCT03327701 ·Status: UNKNOWN ·Phase: PHASE3
-
Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics
NCT00252291 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
NCT01435902 ·Status: WITHDRAWN ·Phase: PHASE3
-
Genetic Epidemiology of Asthma in Costa Rica
NCT00021840 ·Status: COMPLETED
-
Study In Asthma Control
NCT00273026 ·Status: TERMINATED ·Phase: PHASE4
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness
NCT00605410 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
NCT01747629 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913 ·Status: RECRUITING ·Phase: PHASE4
-
Genetic Determinants of the Response to Salbutamol Among Asthma Patients
NCT00162396 ·Status: UNKNOWN ·Phase: NA
-
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma
NCT00452699 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
NCT00603278 ·Status: COMPLETED ·Phase: PHASE2
-
A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma
NCT02680561 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
NCT01156792 ·Status: COMPLETED ·Phase: PHASE2